Does Oritavancin Diphosphate Interact with Warfarin?
Oritavancin Diphosphate and Warfarin have a moderate drug interaction according to U.S. FDA drug labeling data. Oritavancin is a weak CYP2C9 inhibitor. Although a study showed no effect on S-warfarin pharmacokinetics, patients should be monitored closely for bleeding when concomitantly receiving oritavancin and warfarin. The mechanism involves weak cyp2c9 inhibition. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Oritavancin Diphosphate and Warfarin occurs because weak cyp2c9 inhibition. Clinically, this means oritavancin is a weak cyp2c9 inhibitor. although a study showed no effect on s-warfarin pharmacokinetics, patients should be monitored closely for bleeding when concomitantly receiving oritavancin and warfarin. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Oritavancin Diphosphate and your doctor is considering prescribing Warfarin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider